SCHEMBL489490

SCHEMBL489490

CC(C)(C)OC(=O)NC(CC(=O)O)Cc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.70
APP P05067 4/20 0.57
CTSS P25774 3/20 0.56
CTSK P43235 2/20 0.56
CTSL P07711 1/20 0.56
CTSB P07858 1/20 0.56
ACE P12821 1/20 0.54
KLK5 Q9Y337 2/20 0.53
SYK P43405 1/20 0.52
CYP3A4 P08684 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1519945 1.00 ATM (0.70) ATMAPPCTSSCTSKCTSL
SCHEMBL489489 1.00 ATM (0.70) ATMAPPCTSSCTSKCTSL
SCHEMBL825492 0.92 CTSS (0.61) ATMAPPCTSSCTSKCTSL
SCHEMBL3699140 0.92 CTSS (0.61) ATMAPPCTSSCTSKCTSL
SCHEMBL28113260 0.90 ATM (0.68) ATMAPPCTSSCTSKCTSL
SCHEMBL28113259 0.90 ATM (0.68) ATMAPPCTSSCTSKCTSL
SCHEMBL2617274 0.89 ATM (0.58) ATMAPPCTSSCTSKCTSL
SCHEMBL5888032 0.89 ATM (0.58) ATMAPPCTSSCTSKCTSL
SCHEMBL17376003 0.89 ATM (0.67) ATMAPPCTSSCTSKCTSL
SCHEMBL7239876 0.89 ATM (0.67) ATMAPPCTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116874803-A Antibacterial dendritic polyester polymer and preparation method and application thereof 清华大学深圳国际研究生院 2023-10-13 CN claimed
CN-117486762-A Novel compound and use method and application thereof 中国医学科学院医药生物技术研究所 2024-02-02 CN disclosed
CN-116874803-A Antibacterial dendritic polyester polymer and preparation method and application thereof 清华大学深圳国际研究生院 2023-10-13 CN disclosed
CN-116829949-A Compositions for detecting or measuring analytes 伯蒂斯有限公司 2023-09-29 CN disclosed
CN-114341109-A N-formyl hydroxylamines as inhibitors of enkephalinase (NEP), in particular as mixed inhibitors of aminopeptidase N (APN) and enkephalinase (NEP) 领先药物公司 2022-04-12 CN disclosed
EP-3186224-B1 SUBSTITUTED AZETIDINE DERIVATIVES AS TAAR LIGANDS HOFFMANN LA ROCHE (CH) 2021-04-21 EP disclosed
CN-107001259-B Substituted azetidine derivatives as TAAR ligands 豪夫迈·罗氏有限公司 2019-12-06 CN disclosed
US-10023559-B2 Substituted azetidine derivatives HOFFMAN-LA ROCHE INC. (US) 2018-07-17 US disclosed
CN-107001259-A Substituted azetidine derivatives as TAAR ligands 豪夫迈·罗氏有限公司 2017-08-01 CN disclosed
US-20170198006-A1 PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2017-07-13 US disclosed
WO-2005044810-A1 GLYT2 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2005-05-19 WO disclosed
US-20050043346-A1 Pyridylpyrrole derivatives active as kinase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2005-02-24 US disclosed
US-20050043323-A1 Pyrimidylpyrrole derivatives active as kinase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2005-02-24 US disclosed
WO-2005014572-A1 PYRIMIDYLPYRROLE DERIVATIVES ACTIVE AS KINASE INHIBITORS PHARMACIA ITALIA S.P.A. (IT) 2005-02-17 WO disclosed
WO-2005013986-A1 PYRIDYLPYRROLE DERIVATIVES ACTIVE AS KINASE INHIBITORS PHARMACIA ITALIA S.P.A. (IT) 2005-02-17 WO disclosed
US-20030158436-A1 Synthesis of alpha--amino-alpha, alpha'- dihaloketones and process for the preparation of beta--amino acid derivatives by the use of the same KANEKA CORPORATION 2003-08-21 US disclosed
US-6573399-B1 Reacting an alpha -amino acid ester derivative with a base and a dihalomethane KANEKA CORPORATION (JP) 2003-06-03 US disclosed
EP-1078919-A1 SYNTHESIS OF $g(a)-AMINO-$g(a)',$g(a)'-DIHALOKETONES AND PROCESS FOR THE PREPARATION OF $g(b)-AMINO ACID DERIVATIVES BY THE USE OF THE SAME KANEKA CORPORATION (JP) 2001-02-28 EP disclosed
US-4453003-A ENZYME INHIBITORS, ANTIINFLAMMATORY AGENTS UMEZAWA HAMAO (JP) 1984-06-05 US disclosed
US-4281180-A Process for producing threo-3-amino-2-hydroxybutanoyl-aminoacetic acids, as well as novel intermediated therefor and process for producing them NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1981-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043346-A1 Pyridylpyrrole derivatives active as kinase inhibitors MAP3K6, MAP3K5, MAP4K2 ATM 564/4885APP 4392/4885CTSS 4048/4885
US-10023559-B2 Substituted azetidine derivatives HTR1B, MTNR1B, DRD2 ATM 2199/4885APP 1270/4885CTSS 2941/4885
US-20050043323-A1 Pyrimidylpyrrole derivatives active as kinase inhibitors TYMP, DTYMK, DCK ATM 597/4885APP 4358/4885CTSS 4245/4885
US-20030158436-A1 Synthesis of alpha--amino-alpha, alpha'- dihaloketones and process for the preparation of beta--amino acid derivatives by the use of the same AADAT, BCAT1, AASDHPPT ATM 710/4885APP 781/4885CTSS 4485/4885
US-20170198006-A1 PRMT5 INHIBITORS AND USES THEREOF PRMT5, PRMT1, PRMT6 ATM 543/4885APP 3958/4885CTSS 4819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.